PDCD 4 and MIR‐21 are promising biomarkers in the follow‐up of OED in liquid biopsies
Oral Diseases · 2024
DOI: 10.1111/odi.14817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Leyla Arslan Bozdag und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Gazi University, Ankara, Turkey. Hauptthemen laut MEDLINE: MicroRNAs, Mouth Neoplasms, RNA-Binding Proteins, Apoptosis Regulatory Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gazi Üniversitesi.
Abstract (Originalsprache)
This research aims to examine the impact of programmed cell death 4 (PDCD4), microRNA‐21 (miR‐21) and microRNA‐208a (miR‐208a) transcripts, and protein levels on oral epithelial dysplasia (OED) development in oral squamous cell carcinoma (OSCC).
Methods
The research investigation involved the collection of saliva, blood, and tissue samples from a total of 20 patients diagnosed with OSCC, 15 patients diagnosed with OED, and 15 healthy individuals. PDCD4, miR‐21, and miR‐208a expression was performed by quantitative reverse transcription polymerase chain reaction (qRT‐PCR). PDCD4 protein levels were assessed using enzyme‐linked immunosorbent assay (ELISA) in both saliva and blood samples. For statistical analysis, the Kruskal–Wallis test and the Spearmen rank test were utilised.
Results
PDCD4 expression levels were considerably lower in patients with OSCC and OED ( p < 0.05) in three biological samples. In contrast, miR‐21 expression was higher in OED and OSCC patients. Patients with low PDCD4 mRNA levels and strong miR‐21 expression had a significant connection ( p < 0.05) with tumor size and depth.
Conclusions
Examining PDCD 4 and miR‐21 transcript levels may help detect the transition from OED to OSCC. This work suggests that PDCD4 and miR‐21 expression levels in liquid biopsies may be biomarkers for OED monitoring in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Gazi University, Ankara, Turkey.
- Department of Oral, Dental, and Maxillofacial Surgery, Gazi University, Ankara, Turkey.
- Department of Otorhinolaryngology, T.R. Ministry of Health Ankara Etlik City Hospital, Ankara, Turkey.
- Private Office, Ankara, Turkey.
- Department of Oral Pathology, Faculty of Dentistry, Gazi University, Ankara, Turkey.
ORCID-Profile: Leyla Arslan Bozdag
Förderung
- Gazi Üniversitesi
Zitieren
APA
Arslan Bozdag, L., Açik, L., Ersoy, H. E., Bayir, Ö., Korkmaz, M. H., Mollaoglu, N., & Gultekin, S. E. (2024). PDCD 4 and MIR‐21 are promising biomarkers in the follow‐up of OED in liquid biopsies. Oral Diseases. https://doi.org/10.1111/odi.14817
Vancouver
Arslan Bozdag L, Açik L, Ersoy HE, Bayir Ö, Korkmaz MH, Mollaoglu N, et al. PDCD 4 and MIR‐21 are promising biomarkers in the follow‐up of OED in liquid biopsies. Oral Diseases. 2024. doi:10.1111/odi.14817
BibTeX
@article{ArslanBozdag2024,
author = {Arslan Bozdag, Leyla and Açik, Leyla and Ersoy, H Erhan and Bayir, Ömer and Korkmaz, M Hakan and Mollaoglu, Nur and Gultekin, S Elif},
title = {PDCD 4 and MIR‐21 are promising biomarkers in the follow‐up of OED in liquid biopsies},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14817}
}
EUVIMED